Skip to content
Review

Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes

Sep 2026 · Nature Reviews Nephrology · Vol 22, pp. 784 - 802 · 1 citation · 241 references
Medicine

TL;DR

Investigating treatments for CKD possess anti-inflammatory properties that might contribute to their previously established clinical benefits, including renin-angiotensin-aldosterone system inhibitors, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists and non-steroidal mineralocorticoid antagonists, possess anti-inflammatory properties that might contribute to their previously established clinical benefits.

View source

Similar papers

Review Open access Aug 2026

Targeting Inflammation in Chronic Kidney Disease: Pathophysiological Insights and Emerging Therapeutic Strategies

Renin–angiotensin system inhibitors, sodium–glucose cotransporter-2 inhibitors, finerenone, and glucagon-like peptide-1 receptor agonists improve cardiorenal outcomes and have plausible anti-inflammatory actions, although inflammatory mediation remains unproven.

Aris Tsalouchos, P. Dattolo · 0 citations
Review Open access Sep 2026

Signaling pathways in the pathogenesis of diabetic kidney disease (review)

An overview of the key signaling pathways and molecular mediators that underlie typical pathophysiological processes in diabetic kidney disease is presented and central role of transforming growth factor-beta in activating various signaling pathways is noted.

O. A. Nagibovich, A. L. Kovalenko, O. S. Ketlinskaya · 0 citations
Review Open access Sep 2026

The role of inflammation on coronary microvascular dysfunction and potential therapeutic targets

Abstract Coronary microvascular dysfunction (CMD) is a major underlying cause of myocardial ischaemia and is associated with adverse cardiovascular outcomes. It occurs both in the presence of obstructive coronary artery disease (CAD) and in patients with non-obstructive CAD. Emerging evidence highlights chronic inflamm...

Wan-Qi Wang, M. Magistri, John F. Beltrame et al. · 0 citations
Open access Sep 2026

Pathways of oxidative stress and inflammation integration in the pathogenesis of vascular calcification in patients with chronic kidney disease

BACKGROUND. Vascular and cardiac calcification is an important contributor to cardiovascular complications in patients with chronic kidney disease (CKD) and is associated with oxidative stress and persistent low-grade inflammation. However, the interactions between these processes and their contribution to cardiovascul...

F. Dzgoeva, I. В. Tedety, O. Remizov et al. · 0 citations
Open access Aug 2026

miRNA levels are associated with functional physical capacity and inflammation in patients with end-stage kidney disease

Chronic kidney disease (CKD) is a global health problem, especially in the elderly, leading to renal failure through gradual progression and chronic inflammation, in addition to increasing cardiovascular risk. MicroRNAs (miRNAs), non-coding RNAs that regulate gene expression, act as chemical messengers and have been...

Maria Tereza de Oliveira Rodrigues, Abigail Holanda Pierre da Nobrega, R. Neves et al. · 0 citations
Review Sep 2026

MicroRNAs in Renal Fibrosis: Unraveling Mechanisms and Therapeutic Potential.

Chronic Kidney Disease (CKD) poses a growing global health burden, with increasing prevalence driven by risk factors such as aging, metabolic disorders, and environmental influences. As CKD progresses, it frequently leads to renal fibrosis, a pathological condition characterized by excessive extracellular matrix (ECM)...

A. Doghish, Khaled Abuelhaded, M. M. Abdelaziz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.